Compass Therapeutics (CMPX) Net Margin (2024)
Compass Therapeutics (CMPX) has disclosed Net Margin for 1 consecutive years, with 1538.35% as the latest value for Q2 2024.
- Quarterly Net Margin changed N/A to 1538.35% in Q2 2024 from the year-ago period, while the trailing twelve-month figure was 6884.94% through Mar 2025, changed N/A year-over-year, with the annual reading at 6661.76% for FY2024, N/A changed from the prior year.
- Net Margin hit 1538.35% in Q2 2024 for Compass Therapeutics.
- In the past five years, Net Margin ranged from a high of 1538.35% in Q2 2024 to a low of 1538.35% in Q2 2024.